chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My hand and feet and the tops of my thigh kind of started feeling numb; like partially numb;; My hand and feet and the tops of my thigh kind of started feeling numb; like partially numb; then I didn't have like a steady balance or anything; The only thing in my blood work he said my folate was low my B6 was low;  I have never experience what I am experiencing; The only thing in my blood work he said my folate was low my B6 was low;  I have never experience what I am experiencing; They don't feel numb except both my thigh; that they hurt; They don't feel numb except both my thigh; that they hurt and they super sensitive both my feet and my hand; then I am also having involuntary muscle spasm; I am just exhausted I fall sleep right away my body does kind of jerk, jerking motion; I am just exhausted I fall sleep right away my body does kind of jerk, jerking motion; This is a spontaneous report from a contactable consumer (patient). A 60-year-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0175, Expiry date: 31Aug2021) intramuscularly, administered in left arm on 06May2021 as 2nd dose, single dose for COVID-19 immunisation. Medical history included gastroenterology issues. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0162, Expiry date: 31Jul2021) on 15Apr2021 for COVID-19 Immunization. It was reported that patient stated, "Well I am having some issues and I don't know if they related to the vaccine, just kind of want to talk to someone about it." patient stated, "So about maybe I had my second dose of Pfizer may 6th I am just say with then about 7 to 10 days then my hand and feet and the tops of my thigh kind of started feeling numb, like partially numb and then I didn't have like a steady balance or anything and I went to the doctor here a local doctor in, the only thing in my blood work he said my folate was low my B6 was low but I have never experience what I am experiencing and I just wanted to know now they don't feel numb except both my thigh, that they hurt and they super sensitive both my feet and my hand and then I am also having involuntary muscle spasm, when I lay down to go to bed at night like I am just exhausted I fall sleep right away my body does kind of jerk jerking motion, so I don't know if you heard this from another person, when I am this kind of figure out what it was all in May2021" No treatment was received for events. The outcome of events was unknown.  Information on Lot/Batch number was available. Additional information has been requested
cut finger 11JUN92; vax 12JUN92; ADR early sat AM 13JUN92 small knot size of grapefruit, h/a, nausea, vomiting;
About one hour after receiving the shot, he began to have difficulty breathing and tightness in chest.  He did not alert his mother until later that night around 7 pm.  Mother monitored as they were not at home. On his way home, he had a brief period of chest pain of about 10 minutes which then stopped, but the difficulty breathing continued.  The mother called a nurse practitioner friend that advised to listen for crackling sounds or congestion in lungs, the mother did and lungs sounded clear.  NP friend suggested that the mother give Benadryl and monitor through the night (the mother did not want to go to a hospital setting if she could avoid it due to crowded waiting rooms and potential covid exposure). The difficulty breathing went away within an hour and did not return.  Mother continually checked on son during that night and the following days - symptoms did not return. Mother called the dr's office the next week and is awaiting information on if more testing is needed for the reaction.
I had the shingle injection in between the two covid injections.  I've had a itchy rash for 6 weeks on my legs and torso.  Some raised welts and some regular rash.  Nothing over the counter seems to help much.
Information was received from a lawyer concerning a case in litigation involving a female patient. The female was inoculated with ZOSTAVAX vaccine on or about October I, 2015 at a health center as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather, caused the patient to contract a persistent strain of herpes zoster and other complications. On or about November 15, 2015, the patient was treated at a Hospital, for the onset of a severe vesicular rash accompanied by weakened immune symptoms which was diagnosed as severe herpes zoster. On or about November 18, 2015, the was treated by a physician for ongoing and worsening outbreaks of shingle on and near the eye. On or about February 19, 2016, the patient sought additional treatment from another physician for worsening symptoms and pain related to shingles. at which time she was diagnosed with post-herpetic neuralgia; a chronic condition of nerve damage and pain secondary to shingles infections. The patient has also been diagnosed with herpes zoster ophthalmicus, after the shingles spread to her eyes. The patient has been prescribed VALTREX, MOTRIN, acetaminophen and PERCOCET, Valacyclovir, NEURONTIN, and POLYSPORIN ointment for management of her painful and persistent condition. As a direct and proximate result of these malfunctions, the patient has suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result. The patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Outbreak of shingles on or near the eye was considered to be a medically significant event. Additional information has been requested.
A mechanical sound in my left ear, that comes and goes. I wear a hearing aid and I thought it was a problem with my hearing aid but the sound is there when I take the it out. The doctor looked inside for a foreign body due to filters in the hearing aid, they also drained my ear and nothing came out. I will be going to see the ENT clinic next Friday.
22 days following this vaccine there is a rash all over her body and she is being taken to the doctor about it.
Shortness of breath when performing normal exercise routine on Mar 26,27, and 29; Severe itching (pruritis) on Mar 20; minor nausea and fatigue on Mar 19; minor nausea and fatigue on Mar 19; This is a spontaneous report from contactable consumer (patient, self-reported). A 64-years-old female patient received a first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and expiration dates were not reported), via unspecified route of administration in right arm at 18Mar2021 at 04:30 PM, as single dose for COVID-19 immunization. The patient had medical history of high blood pressure, breast cancer in 1994 and Heart attack in 2011. The concomitant medication included acetylsalicylic acid (ASPIRIN (E.C.)) and IRBESARTAN/HCTZ GA. It reported that, on 19Mar2021 at 06:00 AM patient experienced minor nausea and fatigue, Severe itching (pruritis) on 20Mar2021, it continued for over a week and Shortness of breath when performing normal exercise routine on Mar 26, 27, and 29. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, not been tested for COVID-19. There was no known allergies to medications, food, or other products. The pharmacy or drug Store where the vaccine was administered. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of the patient's events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Caller reports she has a friend who experienced myocarditis after vaccination with Comirnaty.; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. Other Case identifier(s): US-PFIZER INC-202101883041.  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDITIS (medically significant), outcome "unknown", described as "Caller reports she has a friend who experienced myocarditis after vaccination with Comirnaty.".  Clinical information: Caller reports she has a friend who experienced myocarditis after vaccination with Comirnaty.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (05Jan2022): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.; Sender's Comments: The information provided is too limited to make a meaningful medical evaluation of the case. However, based on the available information in the case provided, the causal association between the events Myocarditis and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Trunk - anterior and posterior red macular rash. Increase in temperature, irritability 24 hrs later rash extended to all 4 extremities.
This case was reported by a nurse via sales rep and described the occurrence of passed out in a 16-year-old female patient who received FLULAVAL Quadrivalent (batch number Z39X5, expiry date unknown). Co-suspect products included MENACTRA. On 15th November 2017, the patient received FLULAVAL Quadrivalent .5 ml and MENACTRA. On 15th November 2017, less than a day after receiving FLULAVAL Quadrivalent, the patient experienced passed out (serious criteria GSK medically significant) and syncope. On 15th November 2017, the outcome of the syncope was recovered/resolved. On an unknown date, the outcome of the passed out was recovered/resolved. The reporter considered the passed out and syncope to be possibly related to FLULAVAL Quadrivalent. Additional details were provided as follows: The age at vaccination was not reported. The patient received 2 vaccines on the same day, 1 min apart from each other, she received MENACTRA first on her left arm, 1 min later, she received FLULAVAL Quadrivalent on her right arm. She stayed in the room for 15 minutes in case of any reactions and left. After leaving, the mother of the patient called the office that the patient passed out on the floor of the clinic. The patient responded within minutes. The patient was taken back to the examination room and felt well. No treatment was required. This is 1 of 5 cases reported by the same reporter.
Red circular rash around injection site (mildly itchy and warm to touch), soreness at site and under and arm pit, and hardening in and around injection site.
left arm and shoulder blade pain.  pain developed from mid shouderblade, down the arm and into hand. sensations and reflexes normal.
Patient was seen in ER on January 3, 2020. Started on January 2, 2021 she developed chills, and shaking. Noted itching at site and a welt like raised area at site of injection. Patient was treated with anti-histamine for pruritic symptoms. She had no fever, no cough, no pain at site, or any other symptoms. Vital signs were normal 98.3 temp, HR 85, blood pressure 163/87, resp 18 oxygen sat 99%.
No known adverse effects; A 4 month old patient received a dose of PNEUMOVAX; This spontaneous report was received from a medical assistant concerning to a 4 month old patient of unspecified gender. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported.      On 09-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (product administered to patient of inappropriate age) for prophylaxis (lot # S012247 has been verified to be a valid lot number for pneumococcal vaccine, polyvalent (23-valent), expiration date reported as10-FEB-2021) (strength, dose, frequency and route of administration were not reported).   No adverse effects were reported.
"COVID ARM" A large rash with minimal itching, sensitive to the touch that increased in size for 24 hours and is starting to shrink. This started 9 days after the injection.
Chills, nausea, blood sugar remaining high, no appetite,  weak, enzymes high
After vaccine I started hearing ringing in my ears that progressively got worse and required me to get medical assistance
Information has been received from a registered nurse regarding an unknown age and gender patient. On 03-MAR-2012 at 11:30am, ZOSTAVAX, lot # 672477/1604AA was exposed to -12 C for an estimated total time out of range of 4 hours. On 17-APR-2012 at 7:30am, ZOSTAVAX, lot # 672477/1604AA was exposed to -12 C for an estimated total time out of range of 14 hours. On 16-MAY-2012, the patient was administered an out of range dose of ZOSTAVAX, lot# 672477/1604AA expiration date: 13-JAN-2013 (dose and route were not reported). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
No Adverse event; Patient received dose 1 on 01FEB2021 and dose 2 on 17MAR2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received dose 1 on 01FEB2021 and dose 2 on 17MAR2021) and NO ADVERSE EVENT (No Adverse event) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concomitant products included LEVOTHYROXINE, AMLODIPINE, FAMOTIDINE and RALOXIFENE for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received dose 1 on 01FEB2021 and dose 2 on 17MAR2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received dose 1 on 01FEB2021 and dose 2 on 17MAR2021) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.     No treatment medication was provided.   This case was linked to MOD-2022-630469 (Patient Link).
pt recv vax & approx 2wk p/vax pt exp Henoch-Schonlein vasculitis;pt was hosp on tow separate occasions for a total of 10 days;approx 3mo p/onset of sx pt recovered;
white mucous stools with blood; abdominal pain; tenesmus; white mucous stools with blood; fatigue; chills; headache; temp 99.5; This is a spontaneous report from a contactable nurse. This 58-year-old female Nurse (Patient) reported that A 36-year-old female patient received first dose of bnt162b2 (BNT162B2, COVID 19 pfizer, Lot#: EL3246), via an unspecified route of administration on 11Jan2021 01:00 PM on Right arm at single dose for COVID-19 immunisation. She is not pregnant. Medical history was none. Known allergies: NKA. Facility type vaccine was other. No other vaccine in four weeks. Concomitant medications included thyroid (ARMOUR THYROID), estrogens conjugated/medroxyprogesterone acetate (PREMPRO), Regular vitamin.  4:00 am on 20Jan2021 woke with abdominal pain, tenesmus, white mucous stools with blood, fatigue, chills, headache, Temp 99.5 called physician told it sounds like reaction. Took Tylenol 500 mg for symptoms. 21Jan2021 feel better but still mucous blood stools dr wants to see me monday 25Jan2021 if still having blood. AE resulted in: Doctor or other healthcare professional office/clinic visit.  The outcome of the events was recovered with lasting effects. Treatment received. No COVID prior vaccination. No COVID tested post vaccination.; Sender's Comments: Based on the information currently available and in absence of strong confounding factors, a possible contributory role of the suspect BNT162B2 in triggering the onset of blood stool cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Information has been received from a physician concerning a 3 year old female who was vaccinated a couple years before with varicella virus vaccine live. Subsequently, the patient came to the office with a mild chicken pox rash, fever, and less than fifty lesions. There was no product quality complaint involved. The reporter also indicated that the patient's sister (WAES0405USA00653) and another male patient (WAES0403USA02431) had similar experiences following exposure to varicella virus vaccine live. Additional information has been requested.
Red, hot, firm to touch 10cm x 7 cm in diameter. Worsening daily (area getting bigger) symptoms began 7/18. Pt returned to clinic 7/20/15.
Developed MS lesions within a month of getting second dose. I had three active lesions causing parathesis on left side and weakness on right side. I had no MS symptoms before the vaccine, but have had at least 12 lesions since. Could be just a coincidence though.
severe flu like symptoms.  joint pain, upset stomach, chills, body aches, slight fever, lethargy.  Could not get out of bed for more than a few minutes.  Could not read or watch TV, could not sit up for more than a few minutes.  Slept most of the 24 hr period between 11 am on the 22 to 10 am on the 23rd.
Fever-up to 102 F, chills, arm soreness, headache, fever, muscle weakness for 24 hours
This case was reported by a nurse and described the occurrence of dehydration in a 38-year-old female patient who received FLUARIX QUADRIVALENT 2018-2019 season) for prophylaxis. Previously administered products included flu vaccine (was received more than 10 years ago). Additional patient notes included none; healthy. On 2nd October 2018 18:00, the patient received FLUARIX QUADRIVALENT 2018-2019 season (intramuscular) .5 ml. On 2nd October 2018 19:00, 1 hr after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced dizziness and nausea. On 2nd October 2018 22:00, the patient experienced watery diarrhea. On 3rd October 2018, the patient experienced dehydration, vomiting, chills, tremor, lethargy and dry heaves. The patient was treated with ondansetron (Zofran Iv) and sodium chloride (0.9 % Sodium Chloride). On 3rd October 2018, the outcome of the vomiting and chills were recovered/resolved. On 5th October 2018, the outcome of the watery diarrhea was recovered/resolved. On an unknown date, the outcome of the dehydration, dizziness, nausea, lethargy and dry heaves were unknown and the outcome of the tremor was recovered/resolved. The reporter considered the dehydration, dizziness, nausea, watery diarrhea, vomiting, chills, tremor, lethargy and dry heaves to be related to FLUARIX QUADRIVALENT 2018-2019 season. Additional details were provided as follows: The patient received the FLUARIX QUADRIVALENT 2018-2019 season on left arm. Four hours after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced 14 episodes of watery diarrhea. On 3rd October 2018 morning, 1 day after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient felt so lethargic and dehydrated from loss of fluid that she went to the urgent care. On 3rd October 2018, 1 day after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient began vomiting (which was mostly dry heaving) and had severe chills and shaking and watery diarrhea continued. The patient never had a temperature or fever the entire time. The diarrhea continued until 5th October 2018. An intravenous was started and administered IV Zofran, 0.9 percentage sodium chloride 1000 ml plus another 500 ml. The patient was generally healthy and had no immediate or long term medical conditions. No other members of the household had been recently ill. The patient had not eaten anything unusual or traveled outside the country. The patient initially questioned whether this was a GI virus or a reaction to the vaccine. Since her reaction neither her husband or son has become sick. The patient and her family were in close quarters and she  prepare most of the family's food, drinks, etc. Given the time from administration to the onset of the reaction she do believe the above events were related to the vaccine.
A couple days after the vaccine I broke out with a prominent rash and welts all over my body.  It was extremely itchy and warm.  It was so bad I went to the department and were I was given a prescription for nitrofurantoin mono mcr to take for 5 days to help with the discomfort.  I was advised then I had developed a  UTI was also treated for that as well.  I then  reached out to my PCP who then prescribed Benadryl which I took for about 3 mo. I saw my new dr. who stopped the Benadryl and had me start taking Losartan so I alternated the two for about 2 weeks  until I was off the Benadryl and to date I have been off the Benadryl for about 1mo.  No rashes has come back but I still break out in welts and anytime any pressure is applied to my body I break out in welts at the pressured site all over again as well